These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1096853)

  • 21. Mutagenicity experiments on agroclavines, new natural antineoplastic compounds.
    Glatt H; Eich E; Pertz H; Becker C; Oesch F
    Cancer Res; 1987 Apr; 47(7):1811-4. PubMed ID: 3545454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mutagenicity of dinitrotoluenes in Salmonella typhimurium.
    Couch DB; Allen PF; Abernethy DJ
    Mutat Res; 1981 Dec; 90(4):373-83. PubMed ID: 7038460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenicity testing of benomyl, methyl-2-benzimidazole carbamate, streptozotocin and N-methyl-N'-nitro-N-nitrosoguanidine in Salmonella typhimurium in vitro and in rodent host-mediated assays.
    Ficsor G; Bordas S; Stewart SJ
    Mutat Res; 1978 Aug; 51(2):151-64. PubMed ID: 151228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of mutagenic activity in urine samples using a new concentration procedure.
    Duverger-van Bogaert M; Stecca C; Léonard A
    Mutat Res; 1987 May; 178(1):21-4. PubMed ID: 3553913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
    Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cyclophosphamide mutagenicity by beta-carotene.
    Belisario MA; Pecce R; Battista C; Panza N; Pacilio G
    Biomed Pharmacother; 1985; 39(8):445-8. PubMed ID: 3914914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial mutagenic evaluation of Luxabendazole, a new broad spectrum anthelmintic, with the Salmonella typhimurium His- and the Escherichia coli Tryp- reversion tests.
    Ortiz AI; Pollastrini MT; Barea M; Ordóñez D
    Mutagenesis; 1996 Jan; 11(1):27-31. PubMed ID: 8671711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific mutagenic effectiveness of 1,4-bis-diazoacetylbutane in relation to individual genes].
    Vasil'eva SV; Rapoport IA
    Genetika; 1977; 13(1):132-7. PubMed ID: 348566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial mutation studies with tetrachlorvinphos (Gardona)).
    Brooks TM; Dean BJ; Hutson DH; Potter D
    Mutat Res; 1982 Oct; 105(4):211-21. PubMed ID: 6752704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of nitrosamines and other carcinogens by mouse-liver S9, mouse hepatocytes and in the host-mediated assay produces different mutagenic responses in Salmonella TA1535.
    Kerklaan P; Bouter S; Mohn G
    Mutat Res; 1983; 110(1):9-22. PubMed ID: 6865998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenic evaluation of the hair-dye component 2,4-diaminophenoxyethanol in Salmonella typhimurium/microsome plate test and Saccharomyces cerevisiae strains D4 and XV185-14C.
    Shahin MM; Bugaut A; Kalopissis G
    Mutat Res; 1982 Dec; 102(4):319-29. PubMed ID: 6757736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenic activity of three isomeric N-nitroso-N-methylaminopyridines towards Escherichia coli K-12 in in vitro and animal-mediated assays.
    Kerklaan P; Bouter S; Mohn G
    Carcinogenesis; 1982; 3(4):415-21. PubMed ID: 7046976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing of 2,4,5-T-amino acid conjugates for mutagenic activity in Salmonella typhimurium strains.
    Rashid KA; Babish JG; Mumma RO
    Mutat Res; 1984 Jun; 136(3):217-21. PubMed ID: 6377058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soil mutagens are airborne mutagens: variation of mutagenic activities induced in Salmonella typhimurium TA 98 and TA 100 by organic extracts of agricultural and forest soils in dependence on location and season.
    Edenharder R; Ortseifen M; Koch M; Wesp HF
    Mutat Res; 2000 Dec; 472(1-2):23-36. PubMed ID: 11113695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity of styrene in the Salmonella typhimurium test system.
    de Meester C; Duverger-van Bogaert M; Lambotte-Vandepaer M; Mercier M; Poncelet F
    Mutat Res; 1981 Dec; 90(4):443-50. PubMed ID: 7038463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenic activities of cyclophosphamide (NSC-26271) and its main metabolites in Salmonella typhimurium, human peripheral lymphocytes and Chinese hamster ovary cells.
    Winckler K; Obe G; Madle S; Nau H
    Mutat Res; 1984 Oct; 129(1):47-55. PubMed ID: 6387470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of methyl nitrite in Salmonella typhimurium.
    Törnqvist M; Rannug U; Jonsson A; Ehrenberg L
    Mutat Res; 1983 Apr; 117(1-2):47-54. PubMed ID: 6339910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity assay with Salmonella typhimurium revealing biotransformation of antiphytoviral substances by cell-free plant extract.
    el-Tarras A; Braun R; Stenz E; Schuster G
    Zentralbl Mikrobiol; 1989; 144(3):197-202. PubMed ID: 2672682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.
    Balbinder E; Reich CI; Shugarts D; Keogh J; Fibiger R; Jones T; Banks A
    Cancer Res; 1981 Jul; 41(7):2967-72. PubMed ID: 7018675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.